Ex-vivo T-cell depletion with sequential CD34+selection and OKT3 depletion for graft versus host disease prophylaxis in related haplo-identical allogeneic stem cell transplant.

被引：0
|
作者：
McGuirk, J [1 ]
Seropian, S [1 ]
Berliner, N [1 ]
Sleight, B [1 ]
Beardsley, D [1 ]
Debelak, J [1 ]
Krause, DS [1 ]
Smith, B [1 ]
Cooper, D [1 ]
机构：
[1] Yale Univ, New Haven Hosp, New Haven, CT USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4986
引用
收藏
页码：393B / 393B
页数：1
相关论文
共 50 条
  • [31] GRAFT VERSUS HOST-DISEASE AND IMMUNOLOGICAL RECONSTITUTION IN BONE-MARROW TRANSPLANT RECIPIENTS OF RELATED AND UNRELATED GRAFTS USING TOTAL T-CELL DEPLETION
    HEDDERMAN, A
    TRICOT, G
    BALLAS, CB
    LEEMHUIS, T
    GRIGSBY, S
    GRAVES, V
    HOFFMAN, R
    LEBKOWSKI, J
    SROUR, EF
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 707 - 707
  • [32] T-cell depletion of bone marrow grafts with Campath 1 ex vivo prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation
    Novitzky, N
    Thomas, V
    Hale, G
    Waldmann, H
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 299 - 299
  • [33] Haploidentical Hematopoietic Stem Cell Transplantation in Children with High Risk Hematologic Malignancies: Outcomes with Two Different Strategies for Graft-Versus Host-Disease Prevention: Ex Vivo T-Cell Depletion and Post-Transplant Cyclophosphamide
    Dufort, Gustavo
    Castillo, Luis
    Pisano, Silvia
    Castiglioni, Mariela
    Pages, Carolina
    Incoronato, Andrea
    Simon, Elizabeth
    Zuccolo, Silvana
    Schelotto, Magdalena
    Morosini, Fabiana
    Guerrero, Lujan
    Dabezies, Agustin
    Decaro, Jorge
    Giordano, Hugo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S370 - S370
  • [34] CD34+ selection using density gradient separation does not reduce the risk of graft vs host disease after allogeneic peripheral blood stem cell (PBSC) transplant.
    Vij, R
    Brown, R
    Haug, JS
    Todd, G
    Adkins, D
    Goodnough, LT
    Khoury, H
    Westervelt, P
    DiPersio, J
    BLOOD, 1998, 92 (10) : 649A - 649A
  • [35] Depletion of naive lymphocytes with Fas-ligand ex vivo prevents graft-versus-host disease while maintaining T-cell support of engraftment and graft-versus-tumour activity
    Askenasy, N.
    Yaniv, I.
    Stein, J.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S253 - S253
  • [36] Graft-Vs-Host Disease (GvHD) Prophylaxis with Post-Transplant Cyclophosphamide (PTCy) and Thymoglobulin (ATG) Are More Important Determinants of Cytomegalovirus (CMV) Reactivation after Allogeneic Hematopoietic Cell Transplantation (HCT) Than Ex-Vivo T-Cell Depletion in the Era of Pre-Emptive Therapy
    Chong, Lip Leong
    Chia, Chelsea
    Koh, Yin Teng
    Boo, Yang Liang
    Lee, Chun Tsu
    Poon, Michelle
    Tan, Lip Kun
    Koh, Liang Piu
    BLOOD, 2021, 138
  • [37] T-Cell Depletion Improves the Composite End Point Graft-Versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation
    Simonetta, Federico
    Masouridi-Levrat, Stavroula
    Beauverd, Yen
    Tsopra, Olga
    Tirefort, Yordanka
    Stephan, Caroline
    Polchlopek, Karolina
    Favale, Riccardo
    Dentin, Carole
    Ansari, Marc
    Roosnek, Eddy
    Chalandon, Yves
    BLOOD, 2015, 126 (23)
  • [38] Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation
    Simonetta, Federico
    Masouridi-Levrat, Stavroula
    Beauverd, Yan
    Tsopra, Olga
    Tirefort, Yordanka
    Koutsi, Aikaterini
    Stephan, Caroline
    Polchlopek-Blasiak, Karolina
    Pradier, Amandine
    Dantin, Carole
    Ansari, Marc
    Roosnek, Eddy
    Chalandon, Yves
    LEUKEMIA & LYMPHOMA, 2018, 59 (03) : 590 - 600
  • [39] T-cell depletion improves the composite end point graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation
    Simonetta, F.
    Masouridi-Levrat, S.
    Beauverd, Y.
    Tsopra, O.
    Tirefort, Y.
    Stephan, C.
    Polchlopek, K.
    Favale, R.
    Dantin, C.
    Ansari, M.
    Roosnek, E.
    Chalandon, Y.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S223 - S224
  • [40] Ex vivo T-cell depletion of bone marrow grafts with campath 1 prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation.
    Novitzky, N
    Thomas, V
    Hale, G
    Waldmann, H
    BLOOD, 1997, 90 (10) : 4506 - 4506
12345